Palvella Therapeutics (PVLA) Capital Expenditures (QoQ) (2014 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -267.27% |
| Sep 30, 2023 | 323.08% |
| Jun 30, 2023 | -45.83% |
| Mar 31, 2023 | -95.25% |
| Dec 31, 2022 | 6,212.50% |
| Sep 30, 2022 | 105.65% |
| Jun 30, 2022 | -194.97% |
| Mar 31, 2022 | -68.60% |
| Dec 31, 2021 | 469.26% |
| Sep 30, 2021 | -212.23% |
| Jun 30, 2021 | 717.86% |
| Mar 31, 2021 | -95.16% |
| Dec 31, 2020 | 168.81% |
| Sep 30, 2020 | -179.17% |
| Jun 30, 2020 | -44.94% |
| Mar 31, 2020 | 63.86% |
| Dec 31, 2019 | 406.90% |
| Sep 30, 2019 | -75.13% |
| Jun 30, 2019 | 671.07% |
| Mar 31, 2019 | -78.58% |
| Dec 31, 2018 | 73.85% |
| Sep 30, 2018 | -17.51% |
| Jun 30, 2018 | -4.83% |
| Mar 31, 2018 | -49.45% |
| Dec 31, 2017 | 183.39% |
| Sep 30, 2017 | -56.41% |
| Jun 30, 2017 | 270.39% |
| Mar 31, 2017 | -24.57% |
| Dec 31, 2016 | 19.79% |
| Sep 30, 2016 | 249.45% |
| Jun 30, 2016 | -16.53% |
| Mar 31, 2016 | -80.68% |
| Dec 31, 2015 | 80.27% |
| Sep 30, 2015 | 479.64% |
| Jun 30, 2015 | -17.25% |
| Jun 30, 2014 | 180.60% |